马凡患者择期保留瓣膜主动脉根部置换时是否需预防性替换非动脉瘤性主动脉弓?
该单中心回顾性研究纳入1993至2021年间67例马凡综合征患者,均因孤立性主动脉根部动脉瘤行择期David I手术(仅替换根部及升主动脉)。随访显示20年生存率85%,因弓部动脉瘤再手术免除率95%,无患者因弓部动脉瘤行弓部替换,3例因B型夹层行弓部替换。结论支持对非动脉瘤性主动脉弓不进行预防性替换。
要点
- 马凡患者择期David I术后因弓部动脉瘤再干预风险极低。
- 20年因弓部动脉瘤再手术免除率为95%。
- 非动脉瘤性主动脉弓不推荐预防性替换。
核心结论
- 马凡综合征患者择期行保留瓣膜的主动脉根部置换(David I手术)后,远期因主动脉弓动脉瘤再干预的风险极低。
- 研究支持对非动脉瘤性主动脉弓不进行同期预防性替换。
研究设计与样本
- 单中心回顾性研究,1993至2021年共723例患者行David I手术,其中119例确诊马凡病。
- 纳入67例孤立性主动脉根部动脉瘤、无主动脉弓病理的马凡患者,均择期行孤立David I手术(仅替换主动脉根部和升主动脉),无同期其他手术。
主要发现
- 患者中位年龄30岁(20-41),男性47例(70%)。
- 体外循环时间157.5(145.8-178.3)分钟,主动脉阻断时间117.0 ± 19.8分钟。
- 院内死亡率和卒中率均为0%,随访完整率100%。
- 1、5、10、15、20年生存率分别为100%、100%、93%、89%、85%。
- 因主动脉弓动脉瘤再手术免除率在1、5、10、15、20年分别为100%、100%、100%、100%、95%;随访中无患者因弓部动脉瘤行弓部替换;3例因B型主动脉夹层行弓部替换(1例慢性B型夹层伴动脉瘤,2例急性B型夹层)。
临床怎么用
- 在马凡综合征患者择期行保留瓣膜的主动脉根部置换时,若主动脉弓无动脉瘤,可不进行预防性弓部替换。
- 术后仍需长期随访监测主动脉弓及远端主动脉,警惕B型主动脉夹层等事件。
局限性
- 回顾性单中心研究,样本量有限(67例马凡患者)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valve-sparing aortic root replacement has increasingly been performed in Marfan patients. However, there is ongoing debate on whether the non-aneurysmal sized aortic arch should be prophylactically replaced during the index operation. The aim of our retrospective single-centre study was to investigate the long-term status of the aortic arch in these patients. METHODS: Between 1993 and 2021, a total of 723 patients underwent valve-sparing aortic root replacement with a straight tube graft (David I reimplantation) at our institution; 119 patients had confirmed Marfan disease. Of these 119 Marfan patients, 67 patients had isolated aortic root aneurysm with no aortic arch pathology. These 67 patients underwent isolated David I procedure in an elective setting (only aortic root and ascending aortic replacement) without any concomitant procedures and were included in the present study. RESULTS: This study includes 67 patients with Marfan syndrome who underwent isolated elective valve-sparing aortic root replacement. The median age of patients was 30 years (20-41), and 47 were male (70%). The cardiopulmonary time was 157.5 (145.8-178.3) min, and aortic clamp time was 117.0 ± 19.8 min. The in-hospital mortality and stroke rates were both 0%. Follow-up was 100% complete. Survival at 1, 5, 10, 15, and 20 years were 100%, 100%, 93%, 89%, and 85%, respectively. Freedom from aortic arch reoperation due to aneurysm at 1, 5, 10, 15, and 20 years was 100%, 100%, 100%, 100%, and 95%, respectively. In follow-up, no patient required aortic arch replacement due to aortic arch aneurysm. A total of 3 patients underwent aortic arch replacement for type B aortic dissection. Of these 3 patients, 1 had chronic type B dissection with aortic aneurysm, and 2 had acute type B dissection. CONCLUSIONS: The long-term results after valve-sparing aortic root replacement with a straight tube graft (David I procedure) in Marfan patients are excellent. Our study shows that the risk for future aortic arch intervention after elective valve sparing aortic root replacement in Marfan patients is extremely low. Hence, our study supports the idea that concomitant prophylactic aortic arch replacement during elective valve sparing aortic root replacement in Marfan patients with non-aneurysmal aortic arch is not necessary.
引用
- Shrestha M, Kaufeld T, Rudolph L, et al. Should We Replace the Non-Aneurysmal Aortic Arch During Elective Valve-Sparing Aortic Root Replacement in Marfan Patients? Eur J Cardiothorac Surg. 2026. PMID: 41442164. doi:10.1093/ejcts/ezaf417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。